Stock LHU LEMAITRE VASCULAR, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. LeMaitre Vascular, Inc. Deutsche Boerse AG

Equities

LHU

US5255582018

Market Closed - Deutsche Boerse AG
Other stock markets
 05:29:33 2024-07-12 am EDT 		5-day change 1st Jan Change
77 EUR +1.32% Intraday chart for LeMaitre Vascular, Inc. +4.05% +48.08%
Jul. 01 LeMaitre Vascular, Inc.(NasdaqGM:LMAT) dropped from Russell 3000E Index CI
Jul. 01 LeMaitre Vascular, Inc.(NasdaqGM:LMAT) dropped from Russell Microcap Index CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target
MT
Lemaitre Vascular Insider Sold Shares Worth $9,314,501, According to a Recent SEC Filing
MT
Lemaitre Vascular Insider Sold Shares Worth $379,991, According to a Recent SEC Filing
MT
Barrington Boosts Price Target on LeMaitre Vascular to $79 From $69, Keeps Outperform Rating
MT
Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59
MT
Barrington Raises Price Target on LeMaitre Vascular to $69 From $66, Keeps Outperform Rating
MT
JMP Securities Initiates LeMaitre Vascular With Market Outperform Rating, Price Target is $60
MT
Oppenheimer Initiates Coverage on LeMaitre Vascular With Outperform Rating, $70 Price Target
MT
Jefferies Downgrades LeMaitre Vascular to Hold From Buy, Adjusts Price Target to $67 From $63
MT
Barrington Raises Price Target on LeMaitre Vascular to $66 From $62, Maintains Outperform Rating
MT
Stifel Raises LeMaitre Vascular's Price Target to $60 From $48, Hold Rating Kept
MT
Jefferies Raises LeMaitre Vascular's Price Target to $63 From $57, Maintains Buy Rating
MT
Roth MKM Raises LeMaitre Vascular's Price Target to $54 From $48, Neutral Rating Kept
MT
Barrington Research Upgrades LeMaitre Vascular to Outperform From Market Perform
MT
Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform
MT
Barrington Lowers LeMaitre Vascular's Price Target to $50 From $54, Maintains Outperform Rating
MT
Barrington Research Trims LeMaitre Vascular's Price Target to $54 From $62, Maintains Outperform Rating
MT
Barrington Adjusts Price Target on LeMaitre Vascular to $62 From $64, Maintains Outperform Rating
MT
LEMAITRE VASCULAR : Jefferies Initiates LeMaitre Vascular at Buy Rating With $70 Price Target
MT
LEMAITRE VASCULAR : Roth Capital Adjusts LeMaitre Vascular's Price Target to $58 from $55, Keeps Neutral Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LMAT Stock
  4. LHU Stock
  5. News LeMaitre Vascular, Inc.
  6. Analyst Reco.